{"disease":{"id":"sickle-cell-thalassemia","name":"sickle cell thalassemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05799118","title":"Study of the Role of Genetic Modifiers in Hemoglobinopathies","phase":"","overall_status":"RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Cyprus Institute of Neurology and Genetics","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06831799","title":"ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT06609226","title":"A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01913548","title":"Multi-Center Study of Iron Overload: Survey Study (MCSIO)","phase":"","overall_status":"COMPLETED","enrollment_count":423,"lead_sponsor_name":"UCSF Benioff Children's Hospital Oakland","has_results":false},{"nct_id":"NCT05255445","title":"Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Westat","has_results":false},{"nct_id":"NCT05506358","title":"Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada","phase":"NA","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"University of British Columbia","has_results":true},{"nct_id":"NCT03376893","title":"Epidemiology of Silent and Overt Strokes in Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06313398","title":"Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04691323","title":"The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT02998450","title":"A Study of IMR-687 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Cardurion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02105766","title":"Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT04987489","title":"A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Forma Therapeutics, Inc.","has_results":false},{"nct_id":"NCT01158794","title":"Genes Influencing Iron Overload State","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT03176849","title":"A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Phoenix Children's Hospital","has_results":false},{"nct_id":"NCT04678037","title":"Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT05357482","title":"Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04688411","title":"An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT02179359","title":"Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies","phase":"NA","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT06813924","title":"A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04675645","title":"Adherence to HU and HRQOL in Patients With Sickle Cell Disease: An Intervention Study Using HU-Go App","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":false},{"nct_id":"NCT03763656","title":"Pharmacokinetics of Oral Hydroxyurea Solution","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Nova Laboratories Limited","has_results":true},{"nct_id":"NCT07023029","title":"A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03333486","title":"Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":31,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT00669305","title":"Bone Marrow for Hemoglobinopathy Research","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT05904093","title":"Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06581627","title":"A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05736419","title":"A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04579926","title":"PINPOINT: Gaming Technology for SCD Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Klein Buendel, Inc.","has_results":true},{"nct_id":"NCT01114776","title":"Multi-Center Study of Iron Overload: Pilot Study","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"UCSF Benioff Children's Hospital Oakland","has_results":false},{"nct_id":"NCT04099966","title":"AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Mitchell Cairo","has_results":false},{"nct_id":"NCT06433661","title":"A Research Study of the Effect of Food on Etavopivat in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04523376","title":"Pilot Study PBSCT with TCRab Depletion for Hemoglobinopathies","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Timothy Olson","has_results":false},{"nct_id":"NCT05675436","title":"Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT03367546","title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT05414045","title":"Autologous Testicular Tissue Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT03653338","title":"T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT03249831","title":"A Blood Stem Cell Transplant for Sickle Cell Disease","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT02212535","title":"Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03825341","title":"Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":true}],"total":40},"guidelines":[],"source":"Drug Landscape verified database"}